{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:03:37Z","timestamp":1770750217448,"version":"3.50.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Debiopharm","award":["12733"],"award-info":[{"award-number":["12733"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227715","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T13:28:07Z","timestamp":1579872487000},"page":"e0227715","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice"],"prefix":"10.1371","volume":"15","author":[{"given":"Michael","family":"Bobardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udayan","family":"Chatterji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregoire","family":"Vuagniaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-4764","authenticated-orcid":true,"given":"Philippe","family":"Gallay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"pone.0227715.ref001","unstructured":"UNAIDS (2016) UNAIDS 2016 Global Fact Sheet."},{"key":"pone.0227715.ref002","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"P Borrow","year":"1994","journal-title":"J Virol"},{"key":"pone.0227715.ref003","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"RA Koup","year":"1994","journal-title":"J Virol"},{"key":"pone.0227715.ref004","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/370463a0","article-title":"Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV","volume":"370","author":"G Pantaleo","year":"1994","journal-title":"Nature"},{"key":"pone.0227715.ref005","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.2431484","article-title":"CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication","volume":"234","author":"CM Walker","year":"1986","journal-title":"Science"},{"key":"pone.0227715.ref006","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"JE Schmitz","year":"1999","journal-title":"Science"},{"key":"pone.0227715.ref007","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1128\/JVI.70.9.5799-5806.1996","article-title":"Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes","volume":"70","author":"OO Yang","year":"1996","journal-title":"J Virol"},{"key":"pone.0227715.ref008","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1086\/339678","article-title":"Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5","volume":"185","author":"OO Yang","year":"2002","journal-title":"J Infect Dis"},{"key":"pone.0227715.ref009","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1128\/JVI.73.6.4582-4589.1999","article-title":"Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4","volume":"73","author":"OO Yang","year":"1999","journal-title":"J Virol"},{"key":"pone.0227715.ref010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/36129","article-title":"Beta chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans","volume":"391","author":"L Wagner","year":"1998","journal-title":"Nature"},{"key":"pone.0227715.ref011","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1128\/JVI.71.4.3120-3128.1997","article-title":"Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms","volume":"71","author":"OO Yang","year":"1997","journal-title":"J Virol"},{"key":"pone.0227715.ref012","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV suppressive factors produced by CD8+ T cells","volume":"270","author":"F Cocchi","year":"1995","journal-title":"Science"},{"key":"pone.0227715.ref013","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"AJ Zajac","year":"1998","journal-title":"J Exp Med"},{"key":"pone.0227715.ref014","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/JVI.78.11.5535-5545.2004","article-title":"Memory CD8 T-cell differentiation during viral infection","volume":"78","author":"EJ Wherry","year":"2004","journal-title":"J Virol"},{"key":"pone.0227715.ref015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"DL Barber","year":"2006","journal-title":"Nature"},{"key":"pone.0227715.ref016","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"CL Day","year":"2006","journal-title":"Nature"},{"key":"pone.0227715.ref017","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20061496","article-title":"PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection","volume":"203","author":"C Petrovas","year":"2006","journal-title":"J Exp Med"},{"key":"pone.0227715.ref018","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"L Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"pone.0227715.ref019","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV specific immunity in vivo by PD-1 blockade","volume":"458","author":"V Velu","year":"2009","journal-title":"Nature"},{"issue":"5","key":"pone.0227715.ref020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/eji.201646875","article-title":"Immune checkpoints and their inhibition in cancer and infectious diseases","volume":"47","author":"L Dyck","year":"2017","journal-title":"Eur J Immunol"},{"key":"pone.0227715.ref021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijid.2017.01.028","article-title":"Anti-PD-1\/PD-L1 therapy for infectious diseases: learning from the cancer paradigm","volume":"56","author":"M Rao","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"3","key":"pone.0227715.ref022","first-page":"219","article-title":"PD-1 coinhibitory signals: the link between pathogenesis and protection","volume":"25","author":"DA Kulpa","journal-title":"Semin Immunol. 2013"},{"issue":"1","key":"pone.0227715.ref023","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11904-011-0106-4","article-title":"Role of PD-1 in HIV pathogenesis and as target for therapy","volume":"9","author":"F Porichis","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"pone.0227715.ref024","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/157488712799363262","article-title":"Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1\/PD-L1 interaction","volume":"7","author":"P Sakthivel","year":"2012","journal-title":"Rev Recent Clin Trials"},{"issue":"10","key":"pone.0227715.ref025","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.4049\/jimmunol.0803771","article-title":"PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention","volume":"182","author":"DE Kaufmann","year":"2009","journal-title":"J Immunol"},{"issue":"7","key":"pone.0227715.ref026","doi-asserted-by":"crossref","first-page":"e1005661","DOI":"10.1371\/journal.ppat.1005661","article-title":"Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection","volume":"12","author":"M Hoffmann","year":"2016","journal-title":"PLoS Pathog"},{"key":"pone.0227715.ref027","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1038\/ncomms9495","article-title":"Immunological biomarkers predict HIV-1 viral rebound after treatment interruption","volume":"6","author":"J Hurst","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"pone.0227715.ref028","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.4049\/jimmunol.1200646","article-title":"Programmed death-1 is a marker for abnormal distribution of naive\/memory T cell subsets in HIV-1 infection","volume":"191","author":"G Breton","year":"2013","journal-title":"J Immunol"},{"issue":"27","key":"pone.0227715.ref029","doi-asserted-by":"crossref","first-page":"E2480","DOI":"10.1073\/pnas.1305394110","article-title":"Strength of PD-1 signaling differentially affects T-cell effector functions","volume":"110","author":"F Wei","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"pone.0227715.ref030","article-title":"The inhibitor of apoptosis protein (IAP) antagonist Debio 1143 enhances the immune response to anti-PD1\/L1 inhibitors in vitro and in vivo","volume":"78","author":"A Attinger","year":"2018","journal-title":"Cancer Research"},{"issue":"9","key":"pone.0227715.ref031","first-page":"787","article-title":"Regulation of innate and adaptive antitumor immunity by IAP antagonists","volume":"10","author":"SK Dougan","journal-title":"Immunotherapy. 2018"},{"issue":"11","key":"pone.0227715.ref032","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2012.06.004","article-title":"Modulation of immune signalling by inhibitors of apoptosis","volume":"33","author":"ST Beug","year":"2012","journal-title":"Trends Immunol"},{"issue":"9","key":"pone.0227715.ref033","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1038\/cddis.2013.311","article-title":"RajalingamK. IAPs on the move: role of inhibitors of apoptosis proteins in cell migration","volume":"4","author":"TK Oberoi-Khanuja","year":"2013","journal-title":"Cell Death Dis"},{"issue":"1","key":"pone.0227715.ref034","first-page":"1","article-title":"Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B","volume":"1","author":"Y Dai","year":"2009","journal-title":"Am J Transl Res"},{"issue":"7","key":"pone.0227715.ref035","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-7-reviews3009","article-title":"Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs","volume":"2","author":"AM Verhagen","year":"2001","journal-title":"Genome Biol"},{"issue":"2","key":"pone.0227715.ref036","doi-asserted-by":"crossref","first-page":"e0211746","DOI":"10.1371\/journal.pone.0211746","article-title":"The inhibitor apoptosis protein antagonist Debio 1143 is an attractive HIV-1 latency reversal candidate","volume":"14","author":"M Bobardt","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"pone.0227715.ref037","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2012.06.004","article-title":"Modulation of immune signalling by inhibitors of apoptosis","volume":"33","author":"ST Beug","year":"2012","journal-title":"Trends Immunol"},{"issue":"1","key":"pone.0227715.ref038","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2014.05.007","article-title":"Small-Molecule SMAC Mimetics as New Cancer Therapeutics","volume":"144","author":"L Bai","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"6","key":"pone.0227715.ref039","doi-asserted-by":"crossref","first-page":"e21556","DOI":"10.1371\/journal.pone.0021556","article-title":"SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cells","volume":"6","author":"N M\u00fcller-Sienerth","journal-title":"PLoS One 2011"},{"issue":"2","key":"pone.0227715.ref040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00262-012-1342-1","article-title":"Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy","volume":"62","author":"AJ Knights","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"pone.0227715.ref041","doi-asserted-by":"crossref","first-page":"e920","DOI":"10.1038\/cddis.2013.449","article-title":"Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity","volume":"4","author":"D Lecis","year":"2013","journal-title":"Cell Death Dis"},{"issue":"3","key":"pone.0227715.ref042","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/10428194.2013.807925","article-title":"Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing","volume":"55","author":"K Brinkmann","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"pone.0227715.ref043","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/eji.200636600","article-title":"Manipulation of NK cytotoxicity by the IAP family member Livin","volume":"37","author":"B Nachmias","year":"2007","journal-title":"Eur J Immunol"},{"issue":"6","key":"pone.0227715.ref044","first-page":"943","article-title":"Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitro","volume":"4","author":"N Liu","year":"2014","journal-title":"Am J Cancer Res"},{"issue":"3","key":"pone.0227715.ref045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.radonc.2015.05.017","article-title":"The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNF\u03b1-mediated in head and neck squamous cell carcinoma","volume":"116","author":"O Matzinger","journal-title":"Radiother Oncol. 2015"},{"issue":"35","key":"pone.0227715.ref046","doi-asserted-by":"crossref","first-page":"37410","DOI":"10.18632\/oncotarget.6138","article-title":"SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells","volume":"6","author":"CG Langdon","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0227715.ref047","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1038\/s41598-018-35860-z","article-title":"DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death","volume":"8","author":"B Thibault","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0227715.ref048","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1158\/1078-0432.CCR-17-3852","article-title":"SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer","volume":"25","author":"Z Tao","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"15","key":"pone.0227715.ref049","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1200\/JCO.2019.37.15_suppl.2599","article-title":"A dose-finding study of the SMAC mimetic Debio 1143 when given in combination with avelumab to patients with advanced solid malignancies","volume":"37","author":"RA Juergens","year":"2019","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"pone.0227715.ref050","doi-asserted-by":"crossref","first-page":"e77780","DOI":"10.1371\/journal.pone.0077780","article-title":"PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads","volume":"8","author":"E Seung","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"pone.0227715.ref051","doi-asserted-by":"crossref","first-page":"e0184303","DOI":"10.1371\/journal.pone.0184303","article-title":"Prevention of Vaginal and Rectal HIV Transmission by Antiretroviral Combinations in Humanized Mice","volume":"12","author":"PA Gallay","year":"2017","journal-title":"PLoS One"},{"key":"pone.0227715.ref052","first-page":"1","article-title":"Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice","volume":"12","author":"P Gallay","journal-title":"Open Virol J. 2018"},{"key":"pone.0227715.ref053","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune response to EBV and TSST-1","volume":"12","author":"MW Melkus","year":"2006","journal-title":"Nat Med"},{"key":"pone.0227715.ref054","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2005-11-4388","article-title":"Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus\/liver and CD34+ cell transplantation","volume":"108","author":"P Lan","year":"2006","journal-title":"Blood"},{"key":"pone.0227715.ref055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20062411","article-title":"Intrarectal transmission, systemic infection and CD4. T cell depletion in humanized mice infected with HIV-1","volume":"204","author":"Z Sun","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"pone.0227715.ref056","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4049\/jimmunol.1201108","article-title":"In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice","volume":"190","author":"BE Palmer","year":"2013","journal-title":"J Immunol"},{"issue":"14","key":"pone.0227715.ref057","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1128\/JVI.02207-08","article-title":"Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice","volume":"83","author":"DM Brainard","year":"2009","journal-title":"J Virol"},{"issue":"10","key":"pone.0227715.ref058","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"L Trautmann","year":"2006","journal-title":"Nat Med"},{"issue":"10","key":"pone.0227715.ref059","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1084\/jem.20101123","article-title":"IAP inhibitors enhance co-stimulation to promote tumor immunity","volume":"207","author":"M Dougan","year":"2010","journal-title":"J Exp Med"},{"issue":"1","key":"pone.0227715.ref060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.06120-11","article-title":"Generation of HIV latency in humanized BLT mice","volume":"86","author":"PW Denton","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"pone.0227715.ref061","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/JVI.06366-11","article-title":"HIV latency in the humanized BLT mouse","volume":"86","author":"MD Marsden","year":"2012","journal-title":"J Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T13:28:51Z","timestamp":1579872531000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227715"}},"subtitle":[],"editor":[{"given":"Roberto F.","family":"Speck","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227715","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]}}}